{
    "organizations": [],
    "uuid": "3380ac48c9d75440202a82beea96918ed622ec6d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vbl-therapeutics-receives-mileston/brief-vbl-therapeutics-receives-milestone-payment-from-nanocarrier-under-licensing-agreement-for-vb-111-in-japan-idUSASB0C4QY",
    "ord_in_thread": 0,
    "title": "BRIEF-VBL Therapeutics Receives Milestone Payment From Nanocarrier Under Licensing Agreement For VB-111 In Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Vascular Biogenics Ltd:\n* VBL THERAPEUTICS RECEIVES MILESTONE PAYMENT FROM NANOCARRIER UNDER LICENSING AGREEMENT FOR VB-111 IN JAPAN\n* VBL THERAPEUTICS RECEIVES MILESTONE PAYMENT FROM NANOCARRIER UNDER LICENSING AGREEMENT FOR VB-111 IN JAPAN\n* ‍AMOUNT OF RECENT MILESTONE PAYMENT WAS NOT DISCLOSED.​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T20:16:00.000+02:00",
    "crawled": "2018-02-08T14:28:29.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "vascular",
        "biogenics",
        "ltd",
        "vbl",
        "therapeutic",
        "receives",
        "milestone",
        "payment",
        "nanocarrier",
        "licensing",
        "agreement",
        "japan",
        "vbl",
        "therapeutic",
        "receives",
        "milestone",
        "payment",
        "nanocarrier",
        "licensing",
        "agreement",
        "japan",
        "recent",
        "milestone",
        "payment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}